NCT00001444View on ClinicalTrials.gov

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 1995

Study Completion Date

May 31, 2002

Conditions
Breast CancerLymphomaNeoplasmProstatic Neoplasm
Interventions
DRUG

7-hydroxystaurosporine (UCN-01)

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001444 - A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | Biotech Hunter | Biotech Hunter